Frozen Versus Fresh Corneal Carriers for the Boston KPro Type I Donor Carriers

NCT ID: NCT01950598

Last Updated: 2021-01-28

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

37 participants

Study Classification

INTERVENTIONAL

Study Start Date

2013-09-30

Study Completion Date

2020-11-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to determine whether frozen corneas are as safe and effective as fresh corneas for use as carriers with the Boston Keratoprosthesis type I (KPro) over long term follow-up.

Corneal transplantation is typically performed using fresh, transparent corneas. With KPro surgery, the corneal transplant only serves as a carrier to suture the KPro in place. The cornea used in KPro surgery does not need to be clear like a normal transplant. Frozen corneal tissue can be used to repair the cornea in cases of emergency but the tissue is not transparent and does not allow good vision. We hypothesize that frozen grafts are equivalent as fresh grafts when used as carrier for the KPro.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The Boston Keratoprosthesis (KPro) is a collar-button shaped device made from a specialized clear plastic material. This device is used to replace a diseased and opaque cornea with a clear window so that vision can be improved. KPro surgery is an alternative to a traditional corneal graft and is used when a traditional corneal graft has failed or has a very poor probability of success.

During KPro surgery, the KPro needs to be incorporated into a corneal graft before it is sutured to the patient's cornea. The corneal graft serves as a support to the KPro and helps to re-establish vision. The corneas typically used as carriers for the KPro are fresh corneas provided through donors. These fresh corneas are also used in traditional corneal transplantation, without KPro implantation.

Due to shortage of fresh corneas in the province of Quebec, this project is interested in evaluating if corneas that have been previously frozen can act as carriers to the KPro. The frozen corneas cannot be used in traditional corneal transplantation surgery because they are not transparent. However, they can act as a support to the KPro, as in this case, it is the KPro and not the corneal graft that re-establishes vision. The use of frozen corneas for KPro surgery has the potential to improve access to corneal donor tissue and improve the wait-times for KPro surgery.

37 patients were be recruited from the Centre Hospitalier de l'Université de Montréal (CHUM), Notre-Dame Hospital between October 2008 and November 2009. Participants were divided into 2 groups: the first group will receive a KPro in a fresh corneal carrier graft while the second group will receive a KPro in a frozen carrier graft. The use of a fresh or frozen corneal graft depended on the availability of fresh tissue on the morning of surgery. 19 patients received a fresh carrier graft and 18 received a frozen carrier graft.

Patients were followed on postoperative day 1, week 1 and 2, month 1, 3 and 6 and every 1 to 3 months thereafter up to 2 years. At each follow-up visit, a complete ophthalmological examination was performed, including best-corrected Snellen visual acuity and slit lamp assessment for leaks, tissue necrosis, melts, extrusion, inflammation, retroprosthetic membrane formation and infectious endophthalmitis.

The current study aims re-consent patients previously enrolled in this study to prospectively evaluate the long-term outcomes of KPro surgery using either a fresh or frozen carrier graft. IRB approval was obtained from the CHUM. Written informed consent from the concerned patients will be obtained for this extension study during their routine visits at the CHUM Ophthalmology department.

Patients in this study will continue their routine follow-up at the frequency determined by their surgeon, which may vary from every 3 to 6 months.

Outcome measures include surgical feasibility, level of preoperative and postoperative visual acuity (VA), retention of the device and complications as stated above. Outcomes will be compared at 5 and 10 years.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Corneal Blindness Boston Keratoprosthesis Type I Candidate

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Fresh carrier graft for KPro

KPro implanted using fresh cornea, preserved in optisol GS

Group Type ACTIVE_COMPARATOR

Boston KPro type I - fresh graft

Intervention Type PROCEDURE

Boston KPro mounted on fresh corneal carrier graft for implantation

Frozen carrier graft for KPro

KPro implanted using frozen cornea, which was supplied as a whole globe cryopreserved at -80°C in gramicidin 0.025 mg/mL and polymyxin B sulfate 10 000 U/mL ophthalmic solution.

Group Type EXPERIMENTAL

Boston KPro type I surgery - frozen graft

Intervention Type PROCEDURE

Boston KPro mounted on frozen corneal carrier graft for implantation

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Boston KPro type I - fresh graft

Boston KPro mounted on fresh corneal carrier graft for implantation

Intervention Type PROCEDURE

Boston KPro type I surgery - frozen graft

Boston KPro mounted on frozen corneal carrier graft for implantation

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Adult subject over age 18 years
* Boston KPro type I indicated
* history, slit-lamp findings and B-scan do not suggest endstage glaucoma or significant posterior segment disease
* Able to provide informed consent for study inclusion
* Sufficiently healthy to undergo surgery and a vigorous post-operative follow-up course
* Able to administer eye medications or have a care-giver able and willing to do the same
* Corneal blindness with poor prognosis for survival of a traditional penetrating keratoplasty

Exclusion Criteria

* Subject under age 18 years
* History, slit-lamp findings and B-scan suggest endstage glaucoma or significant posterior segment disease
* Not sufficiently healthy to undergo surgery and a vigorous post-operative follow-up course
* Unable to administer eye medication or does not have a care-giver willing to do the same
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Fonds de recherche en ophtalmologie de l'Université de Montréal

OTHER

Sponsor Role collaborator

Marie-Claude Robert

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Marie-Claude Robert

MD, FRSCS

Responsibility Role SPONSOR_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Mona Harissi-Dagher, M.D.

Role: PRINCIPAL_INVESTIGATOR

CHUM - Hôpital Notre-Dame

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Centre Hospitalier de l'Université de Montréal

Montreal, Quebec, Canada

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Canada

References

Explore related publications, articles, or registry entries linked to this study.

Robert MC, Biernacki K, Harissi-Dagher M. Boston keratoprosthesis type 1 surgery: use of frozen versus fresh corneal donor carriers. Cornea. 2012 Apr;31(4):339-45. doi: 10.1097/ICO.0b013e31823e6110.

Reference Type RESULT
PMID: 22269678 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

FvF 08.275

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Corneal Tissue Inlay for Keratoconus
NCT02649738 ACTIVE_NOT_RECRUITING NA
Corneal Sensitivity Cross-linking Keratoconus
NCT01743443 COMPLETED PHASE2/PHASE3